AC Immune SA (ACIU) Earnings Date & Reports

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ACIU is expected to report earnings to fall 907.00% to -16 cents per share on November 10

AC Immune SA ACIU Stock Earnings Reports

Q3'26

Est.

$-0.16

Q2'26

Missed

by $0.08

Q4'25

Beat

by $0.02

Q3'25

Beat

by $0.03

Q2'25

Missed

by $0.04

The last earnings report on August 05 showed earnings per share of 1 cents, missing the estimate of 9 cents. With 202.70K shares outstanding, the current market capitalization sits at 259.50M.

View a ticker or compare two or three

ACIU

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ACIU